196 related articles for article (PubMed ID: 37943820)
1. In Silico identification of novel phytochemicals that target SFRP4: An early biomarker of diabesity.
Rehman A; Bukhari SA; Akhter N; Ijaz Hussain MA; Chauhdary Z
PLoS One; 2023; 18(11):e0292155. PubMed ID: 37943820
[TBL] [Abstract][Full Text] [Related]
2. Finding Novel Anti-carcinomas Compounds by Targeting SFRP4 Through Molecular Modeling, Docking and Dynamic Simulation Studies.
Hassan M; Azhar M; Abbas Q; Raza H; Moustafa AA; Shahzadi S; Ashraf Z; Seo SY
Curr Comput Aided Drug Des; 2018; 14(2):160-173. PubMed ID: 29332600
[TBL] [Abstract][Full Text] [Related]
3. Secreted frizzled-related protein 4 and its implication in obesity and type-2 diabetes.
Bukhari SA; Yasmin A; Zahoor MA; Mustafa G; Sarfraz I; Rasul A
IUBMB Life; 2019 Nov; 71(11):1701-1710. PubMed ID: 31301214
[TBL] [Abstract][Full Text] [Related]
4. Role of secreted frizzled-related protein 4 in prediabetes and type 2 diabetes: a cross sectional study.
Sánchez-Pozos K; Granados-Silvestre MA; Nieto-Velázquez NG; Mejía-Blanquel MA; Galicia-Martínez N; Mandujano-Cerón J; Jaimes-Santoyo J; Ortiz-López MG
BMC Endocr Disord; 2024 Jun; 24(1):78. PubMed ID: 38834984
[TBL] [Abstract][Full Text] [Related]
5. Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes.
Mahdi T; Hänzelmann S; Salehi A; Muhammed SJ; Reinbothe TM; Tang Y; Axelsson AS; Zhou Y; Jing X; Almgren P; Krus U; Taneera J; Blom AM; Lyssenko V; Esguerra JL; Hansson O; Eliasson L; Derry J; Zhang E; Wollheim CB; Groop L; Renström E; Rosengren AH
Cell Metab; 2012 Nov; 16(5):625-33. PubMed ID: 23140642
[TBL] [Abstract][Full Text] [Related]
6. Identification of Ascorbic Acid and Gallic Acid as Novel Inhibitors of Secreted Frizzled-Related Protein for the Treatment of Obesity-Induced Type 2 Diabetes.
Bukhari SA; Yasmin A; Rasul A; Zahoor MA; Mustafa G; Al Farraj DA; Darwish NM; Aleya L; Rehman A
Dose Response; 2022; 20(1):15593258211069707. PubMed ID: 35145353
[TBL] [Abstract][Full Text] [Related]
7. Secreted frizzled-related protein 4 (SFRP4) and fractalkine (CX3CL1) - Potential new biomarkers for β-cell dysfunction and diabetes.
Bergmann K; Sypniewska G
Clin Biochem; 2014 May; 47(7-8):529-32. PubMed ID: 24675103
[TBL] [Abstract][Full Text] [Related]
8. Computer aided screening of secreted frizzled-related protein 4 (SFRP4): a potential control for diabetes mellitus.
Bukhari SA; Shamshari WA; Ur-Rahman M; Zia-Ul-Haq M; Jaafar HZ
Molecules; 2014 Jul; 19(7):10129-36. PubMed ID: 25019556
[TBL] [Abstract][Full Text] [Related]
9. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.
Luo M; Li R; Deng X; Ren M; Chen N; Zeng M; Yan K; Xia J; Liu F; Ma W; Yang Y; Wan Q; Wu J
Acta Diabetol; 2015 Oct; 52(5):943-9. PubMed ID: 25820527
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity.
Villalobos-Labra R; Subiabre M; Toledo F; Pardo F; Sobrevia L
Mol Aspects Med; 2019 Apr; 66():49-61. PubMed ID: 30472165
[TBL] [Abstract][Full Text] [Related]
12. Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease.
Hoffmann MM; Werner C; Böhm M; Laufs U; Winkler K
Cardiovasc Diabetol; 2014 Nov; 13():155. PubMed ID: 25408147
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.
Liu F; Qu H; Li Y; Tang Q; Yang Z; Wang H; Deng H
Endocr J; 2015; 62(8):733-40. PubMed ID: 26041556
[TBL] [Abstract][Full Text] [Related]
14. Loss of SFRP4 Alters Body Size, Food Intake, and Energy Expenditure in Diet-Induced Obese Male Mice.
Mastaitis J; Eckersdorff M; Min S; Xin Y; Cavino K; Aglione J; Okamoto H; Na E; Stitt T; Dominguez MG; Schmahl JP; Lin C; Gale NW; Valenzuela DM; Murphy AJ; Yancopoulos GD; Gromada J
Endocrinology; 2015 Dec; 156(12):4502-10. PubMed ID: 26406932
[TBL] [Abstract][Full Text] [Related]
15. Secreted Frizzled-Related Protein 4 (SFRP4) is Elevated in Patients with Diabetes Mellitus.
Brix JM; Krzizek EC; Hoebaus C; Ludvik B; Schernthaner G; Schernthaner GH
Horm Metab Res; 2016 May; 48(5):345-8. PubMed ID: 26882051
[TBL] [Abstract][Full Text] [Related]
16. Molecular insights of anti-diabetic compounds and its hyaluronic acid conjugates against aldose reductase enzyme through molecular modeling and simulations study-a novel treatment option for inflammatory diabetes.
Jayabal D; Jayanthi S; Thirumalaisamy R; Shimu MSS
J Mol Model; 2023 Jul; 29(8):238. PubMed ID: 37420135
[TBL] [Abstract][Full Text] [Related]
17. Elevated secreted frizzled-related protein 4 in obesity: a potential role in adipose tissue dysfunction.
Garufi G; Seyhan AA; Pasarica M
Obesity (Silver Spring); 2015 Jan; 23(1):24-7. PubMed ID: 25322919
[TBL] [Abstract][Full Text] [Related]
18. Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.
Ji Q; Zhang J; Du Y; Zhu E; Wang Z; Que B; Miao H; Shi S; Qin X; Zhao Y; Zhou Y; Huang F; Nie S
Cardiovasc Diabetol; 2017 Oct; 16(1):133. PubMed ID: 29037197
[TBL] [Abstract][Full Text] [Related]
19. Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options.
Potenza MA; Nacci C; De Salvia MA; Sgarra L; Collino M; Montagnani M
Pharmacol Res; 2017 Jun; 120():226-241. PubMed ID: 28408314
[TBL] [Abstract][Full Text] [Related]
20. Differential Patterns of Secreted Frizzled-Related Protein 4 (SFRP4) in Adipocyte Differentiation: Adipose Depot Specificity.
Guan H; Zhang Y; Gao S; Bai L; Zhao S; Cheng XW; Fan J; Liu E
Cell Physiol Biochem; 2018; 46(5):2149-2164. PubMed ID: 29730658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
